 Cardiogenic hepatorenal syndrome variant hepatorenal syndrome patients chronic congestive heart failure episode cardiogenic pulmonary edema absence hypotension patients eleven-year period clinical picture hepatic injury functional renal impairment Increase serum glutamic oxaloacetic transaminase levels high IU prolongation prothrombin time elevation serum bilirubin creatinine blood urea nitrogen potassium levels decrease urinary sodium excretion normal urinary sediment salient laboratory abnormalities entity conventional medication patients course fatal cases splanchnic vasodilator dopamine patients management patients Cardiogenic hepatorenal syndrome severe reversible complication heart failure beneficial effect low-dose dopamine evaluation